Journal article
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Abstract
AIMS: Risk of Type 2 diabetes varies by ethnicity, but whether ethnicity remains important among those who have impaired glucose tolerance or impaired fasting glucose is uncertain. Whether the effect of thiazolidinedione treatment on diabetes prevention in persons with non-diabetic dysglycaemia varies by ethnicity is also not known. We addressed these questions using data collected in the DREAM trial.
METHODS: A 2-by-2 factorial double-blind …
Authors
Boyko EJ; Gerstein HC; Mohan V; Yusuf S; Sheridan P; Anand S; Shaw JE; investigators FTDT
Journal
Diabetic Medicine, Vol. 27, No. 11, pp. 1226–1232
Publisher
Wiley
Publication Date
November 2010
DOI
10.1111/j.1464-5491.2010.03064.x
ISSN
0742-3071